Compare Avalon Labs (AVL) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avalon Labs vs Enzyme — how do they compare? Avalon Labs trades at Rp396.21 (market cap Rp66,79M, Rp98,78M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 2× Avalon Labs's market cap, and Avalon Labs's supply is capped (161,7M / 1B AVL (17%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 8 Days and Enzyme for 28 Days on average.
| AVL | MLN | |
|---|---|---|
Market Cap | Rp66,79M | Rp134,13M |
Volume (24h) | Rp98,78M | Rp104,56M |
Circulating Supply | 161,7M / 1B AVL (17%) | 3,3M MLN |
Typical Hold Time | 8 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL trades at Rp392.75 with a bearish technical signal, showing selling pressure in moving averages but neutral oscillators. The token hovers near support at Rp393, with resistance at Rp409. Market cap is Rp66.43M with 17% of max supply circulating. Recent news lacks crypto-specific updates, focusing incorrectly on corporate activities.
Outlook remains cautious due to weak technicals and low liquidity. Key risks include high volatility and limited adoption. Opportunities exist if the project gains ecosystem traction, but current fundamentals show no significant developments for token holders.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
